ERBB2 and breast cancer: Based on this, breast cancer is grouped into five groups: luminal A (HR+/HER2−), normal-like (HR+/HER2−), luminal B (HR+/HER2+), HER2 amplification and overexpression, and triple-negative or basal-likes (HR−/HER2−) [29].